Navigation Links
Hazelden President and CEO Ellen Breyer to Step Down April 4
Date:2/22/2008

CENTER CITY, Minn., Feb. 22 /PRNewswire/ -- Hazelden Foundation today announced that Ellen Breyer, President and CEO since 2002, will step down from her position by April 4, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/CGTU038LOGO)

"Ellen leaves behind an impressive record of accomplishment and a legacy that will serve Hazelden well for many years to come," said Norb Conzemius, chairman of the Foundation Board of Trustees. He noted that during her tenure Hazelden became stronger financially, opened the Women's Recovery Center, received accreditation for the Graduate School of Addiction Studies, established the Center for Public Advocacy and managed growth of the world's largest prevention, treatment and recovery publisher.

An active national search has been launched for Breyer's successor. Breyer will remain on hand in a consulting role through June 1, 2008 and will work closely on the transition with the institution's senior management team.

In remarks to staff about her plans, Breyer noted that a number of high-profile projects of her tenure are complete or nearly so. Others still in process, such as planned expansions in New York and Florida, will take years of commitment to see through. Both Breyer and the board, who have been in succession plan discussions, said now is the optimal time to make a leadership transition.

Before coming to Hazelden, Breyer had been vice president of business development and marketing for Ryan Companies, a Minneapolis construction firm, from 1999-2001. Before that she was head of marketing for the law firm of Leonard, Street and Deinard, a Minneapolis law firm, and president and CEO of Truffles Group Inc. from 1988-90. Before moving to Minnesota in 1988 she was director of corporate marketing for Campbell Soup Company/Godiva Chocolatier, Inc., in New York from 1984-1988. Breyer holds an MBA from the Stern School of Business at NYU and continues to be a member of several local and national nonprofit boards.

"The board and organization are deeply grateful to Ellen for her service and wish her every future success," said Conzemius. "As we have for almost 60 years, we'll continue devoting all of our strength and resources to the daunting struggle against addiction to alcohol and other drugs."

Hazelden, a national nonprofit organization founded in 1949, helps people reclaim their lives from the disease of addiction. Built on decades of knowledge and experience, Hazelden offers a comprehensive approach to addiction that addresses the full range of patient, family, and professional needs, including treatment and continuing care for youth and adults, research, higher learning, public education and advocacy, and publishing.


'/>"/>
SOURCE Hazelden Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families
2. Hazelden Publishing Launches Parent Toolkit During National Bullying Prevention Awareness Week
3. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
4. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
5. Sodexho, Inc. Announces Patrick E. Connolly as Market President & COO
6. Pioneer Surgical Technology Hires Vice President of New Business Development
7. PRA International Adds Dr. Susan Stansfield as Executive Vice President
8. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
9. Presidential Candidates Address Health, Financial Security at AARPs Life@50+
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. Resonant Medical Appoints New Vice President of Global Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer ... Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As part of ... anatomic and molecular pathology workflow solution, as well as its new precision medicine ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:2/17/2017)... ST. LOUIS , Feb. 17, 2017   ... hospitals, has announced a new partnership with Engage ... the United States . FormFast will serve ... part of Engage,s implementations with MEDITECH .  ... that provides essential functionality to complement and enhance the ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017  Noble ... coverage on ESSA Pharma Inc. (Nasdaq: EPIX ... Biotechnology Research, Kumar Raja , PhD. ... treatments for castration resistant prostate cancer (CRPC). Its lead ... selectively blocks the amino-terminal domain of the androgen receptor, ...
Breaking Medicine Technology: